Probiotics in Management of Diabetes
Phase 4
Completed
- Conditions
- Health Condition 1: null- Patients diagnosed with Diabetes Mellitus
- Registration Number
- CTRI/2017/06/008761
- Lead Sponsor
- nique Biotech Limited
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 70
Inclusion Criteria
Patients diagnosed with Diabetes Mellitus and willing for the study.
Exclusion Criteria
•Critically ill patients.
•Significant immunodeficiency.
•Use of probiotics within 3 months before inclusion.
•Participation in anyclinical study within the last 6 months.
•Daily alcohol consumption > 30g.
•Systemic antibiotics within 6 weeks before inclusion.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.To evaluate the probiotic mediated Glycemic control & improved quality of life.Timepoint: 30 days
- Secondary Outcome Measures
Name Time Method â?¢To analyse the effects of probiotics on health related quality of life in patients with diabetes mellitus. <br/ ><br>â?¢To assess the patient compliance to the probiotic intake. <br/ ><br>â?¢To determine the effect of probiotics on blood glucose markers such as Fasting blood sugar(FBS), Glycosylated hemoglobin(HbA1C) &Post prandial blood sugar(PPBS). <br/ ><br>Timepoint: NA